Nizoral a-D en es it fr

Nizoral a-D Brand names, Nizoral a-D Analogs

Nizoral a-D Brand Names Mixture

  • No information avaliable

Nizoral a-D Chemical_Formula


Nizoral a-D RX_link

Nizoral a-D fda sheet

Nizoral_a-D FDA

Nizoral a-D msds (material safety sheet)

Nizoral_a-D MSDS

Nizoral a-D Synthesis Reference

J. Heeres et al., U.S. Pat. 4,144,346 (1979)

Nizoral a-D Molecular Weight

531.43 g/mol

Nizoral a-D Melting Point

146 oC

Nizoral a-D H2O Solubility

0.0866 mg/L

Nizoral a-D State


Nizoral a-D LogP


Nizoral a-D Dosage Forms

Tablets; Shampoo; Cream; Suspension

Nizoral a-D Indication

For the treatment of the following systemic fungal infections: candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis.

Nizoral a-D Pharmacology

Ketoconazole, like clotrimazole, fluconazole, itraconazole, and miconazole, is an imidazole antifungal agent.

Nizoral a-D Absorption


Nizoral a-D side effects and Toxicity

Hepatotoxicity, LD50=86 mg/kg (orally in rat)

Nizoral a-D Patient Information

Shampoo: May be irritating to mucous membranes of the eyes and contact with this area should be avoided.

There have been reports that use of the shampoo resulted in removal of the curl from permanently waved hair.

Tablet: Patients should be instructed to report any signs and symptoms which may suggest liver dysfunction so that appropriate biochemical testing can be done. Such signs and symptoms may include unusual fatigue, anorexia, nausea and/or vomiting, jaundice, dark urine or pale stools

Nizoral a-D Organisms Affected